NuPathe's IPO

NuPathe raised a round of funding on August 09, 2010. Investors include Public.

NuPathe is a specialty pharmaceutical company developing therapeutic products for the treatment of neurological and psychiatric diseases. NuPathe's product portfolio includes NP101, which will be a t…

Articles about NuPathe's IPO: